Basophils may have a role in BCG-treated bladder cancer patients because of their ability to facilitate Th2 polarization by secreting proinflammatory interleukins (IL-4 or IL-13) and skewing antigen-presenting cells towards a type 2 response. Here, IL4 is linked to urinary bladder cancer.